Publicaciones en colaboración con investigadores/as de University of Utah (42)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2021

  1. A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

    Blood Cancer Journal

  2. Cardiorespiratory fitness and muscular strength moderates the relationship between fndc5 polymorphism and adiposity in children and adolescents

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 18

  3. Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: A Mendelian randomization study

    American Journal of Clinical Nutrition, Vol. 113, Núm. 6, pp. 1490-1502

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  5. Response to Li and Hopper

    American Journal of Human Genetics

2020

  1. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

    BMC Medicine, Vol. 18, Núm. 1

  2. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses

    Gastroenterology, Vol. 158, Núm. 5, pp. 1300-1312.e20

  3. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

    BMC medicine, Vol. 18, Núm. 1, pp. 229

  4. Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

    Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12

  5. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk

    American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 432-444

  6. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

    Theranostics, Vol. 10, Núm. 23, pp. 10743-10768

  7. Mendelian randomization of circulating polyunsaturated fatty acids and colorectal cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 4, pp. 860-870

2019

  1. Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer (Human Genetics, (2019), 138, 4, (307-326), 10.1007/s00439-019-01989-8)

    Human Genetics

  2. Discovery of common and rare genetic risk variants for colorectal cancer

    Nature Genetics, Vol. 51, Núm. 1, pp. 76-87

  3. Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer

    Human Genetics, Vol. 138, Núm. 4, pp. 307-326

  4. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157

  5. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

    Haematologica, Vol. 104, Núm. 10, pp. 1935-1949

2018

  1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204